Stock ASTH ASTRANA HEALTH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Astrana Health, Inc.

Equities

ASTH

US03763A2078

Healthcare Facilities & Services

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
36.72 USD +0.44% Intraday chart for Astrana Health, Inc. -1.34% -4.13%
Apr. 24 Astrana Health, Inc. Announces Redesignation of Albert Young from Chief Administrative Officer to A New Role as Senior Vice President of Health Affairs CI
Apr. 02 Astrana Health Completes Acquisition of Community Family Care Medical Group MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 642.4 672.2 3,279 1,348 1,706 1,773 - -
Enterprise Value (EV) 1 642.4 672.2 3,279 1,258 1,691 1,696 1,601 1,773
P/E ratio 47.2 x 18.1 x 45.1 x 27.4 x 29.7 x 24.3 x 21.3 x 16.8 x
Yield - - - - - 0.34% - -
Capitalization / Revenue 1.15 x 0.98 x 4.24 x 1.18 x 1.23 x 1.01 x 0.84 x 0.8 x
EV / Revenue 1.15 x 0.98 x 4.24 x 1.1 x 1.22 x 0.96 x 0.75 x 0.8 x
EV / EBITDA 8.62 x 5.31 x 18.9 x 8.99 x 11.5 x 9.62 x 7.77 x 7.36 x
EV / FCF - - - 21.3 x 42.6 x 23.2 x 15.7 x -
FCF Yield - - - 4.7% 2.35% 4.32% 6.36% -
Price to Book - - - 2.49 x 2.92 x 2.56 x 2.33 x -
Nbr of stocks (in thousands) 34,893 36,790 44,623 45,548 44,548 48,291 - -
Reference price 2 18.41 18.27 73.48 29.59 38.30 36.72 36.72 36.72
Announcement Date 3/12/20 3/10/21 2/24/22 2/23/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 560.6 687.2 773.9 1,144 1,387 1,763 2,121 2,227
EBITDA 1 74.5 126.5 173.1 140 146.6 176.2 206.1 241
EBIT 1 34.41 80.5 98.18 104.3 84.61 126.1 152.3 192.1
Operating Margin 6.14% 11.71% 12.69% 9.11% 6.1% 7.15% 7.18% 8.63%
Earnings before Tax (EBT) 1 25.84 178.4 77.75 86.62 89.84 127.1 146 182.6
Net income 1 14.12 37.87 73.86 49.05 60.72 74.95 85.39 110.5
Net margin 2.52% 5.51% 9.54% 4.29% 4.38% 4.25% 4.03% 4.96%
EPS 2 0.3900 1.010 1.630 1.080 1.290 1.510 1.722 2.180
Free Cash Flow 1 - - - 59.19 39.7 73.18 101.8 -
FCF margin - - - 5.17% 2.86% 4.15% 4.8% -
FCF Conversion (EBITDA) - - - 42.27% 27.08% 41.52% 49.42% -
FCF Conversion (Net income) - - - 120.67% 65.38% 97.63% 119.26% -
Dividend per Share 2 - - - - - 0.1247 - -
Announcement Date 3/12/20 3/10/21 2/24/22 2/23/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 227.1 195.1 - - 317 294.2 337.2 348.2 348.2 353 412.6 440.6 446.7 449.3 501.8
EBITDA 1 74.49 38.74 - - 57.14 23.65 29.82 35.77 51.97 29.01 35.42 43.77 57.66 38.01 43.29
EBIT 1 53.16 2.248 - - 50.09 12.58 22.37 27.03 39.08 -3.87 23.85 29.27 43.18 23.98 36.2
Operating Margin 23.41% 1.15% - - 15.8% 4.28% 6.63% 7.76% 11.23% -1.1% 5.78% 6.64% 9.67% 5.34% 7.21%
Earnings before Tax (EBT) 1 -5.505 -22.43 - - 41.26 10.46 19.41 31.49 38.02 0.924 24.09 29.97 47.08 23.12 33.9
Net income 1 34.28 13.77 - - 25.99 -2.6 14.62 13.17 22.06 12.36 14.11 18.73 28.49 10.01 19.9
Net margin 15.09% 7.06% - - 8.2% -0.88% 4.34% 3.78% 6.34% 3.5% 3.42% 4.25% 6.38% 2.23% 3.97%
EPS 2 0.7400 0.3000 0.3100 0.2500 0.5600 -0.0600 0.3100 0.2800 0.4700 0.2600 0.3050 0.3867 0.5600 0.2200 0.4050
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/4/21 2/24/22 5/5/22 8/4/22 11/3/22 2/23/23 5/8/23 8/7/23 11/7/23 2/27/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 - - - 89.6 15.4 77.7 173 -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - - - 59.2 39.7 73.2 102 -
ROE (net income / shareholders' equity) - - - - 10.5% - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 - - - 11.90 13.10 14.40 15.70 -
Cash Flow per Share 2 - - - 1.800 1.450 2.070 - -
Capex 1 - - - 22.9 28.5 27.2 30.4 33.4
Capex / Sales - - - 2% 2.06% 1.54% 1.43% 1.5%
Announcement Date 3/12/20 3/10/21 2/24/22 2/23/23 2/27/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Astrana Health, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
36.72 USD
Average target price
54 USD
Spread / Average Target
+47.06%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
ASTRANA HEALTH, INC. Stock Astrana Health, Inc.
-4.13% 1.77B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.92% 29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-3.06% 16.36B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 14.92B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.75% 11.77B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-1.42% 11.72B
DAVITA INC. Stock DaVita Inc.
+27.44% 11.71B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. ASTH Stock
  4. Financials Astrana Health, Inc.